C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
2.030
0.00 (0.00%)
At close: Jan 6, 2026, 4:00 PM EST
2.040
+0.010 (0.49%)
After-hours: Jan 6, 2026, 4:28 PM EST
C4 Therapeutics Market Cap
C4 Therapeutics has a market cap or net worth of $196.74 million as of January 6, 2026. Its market cap has decreased by -31.18% in one year.
Market Cap
196.74M
Enterprise Value
61.35M
1-Year Change
-31.18%
Ranking
Category
Stock Price
$2.03
Market Cap Chart
Since the IPO on October 2, 2020, C4 Therapeutics's market cap has decreased from $772.72M to $196.74M, a decrease of -74.54%. That is a compound annual growth rate of -22.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 196.74M | 6.28% |
| Dec 31, 2025 | 185.11M | -27.16% |
| Dec 31, 2024 | 254.12M | -8.73% |
| Dec 29, 2023 | 278.44M | -3.60% |
| Dec 30, 2022 | 288.85M | -81.55% |
| Dec 31, 2021 | 1.57B | 9.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |